The metabolic demands of the CNS require that numerous compounds be bidirectionally transported across the bloodbrain barrier
As GLP-1 receptor agonists gain wider use for metabolic disease and weight management, dermatologists, primary care clinicians, researchers, and patients are seeking clear information about possible cutaneous effects, rare adverse events, and potential therapeutic interactions
Clinical studies used vastly different protocols
However, these sources of support exert no influence on the data or conclusions summarized in the present review
2016;8(12) Smith AD, Warren MJ, Refsum H
The best option depends on your goal